Page last updated: 2024-08-18

allylamine and Adverse Drug Event

allylamine has been researched along with Adverse Drug Event in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (20.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	2 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fonseca, VA; Ford, DM; Goldfine, AB; Jones, MR; Truitt, KE; Wang, AC	1
Hopkins, PN; Karki, S; Marais, AD; Melino, M; Misir, S; Raal, FJ; Schurr, D; Stein, EA; Szamosi, T; Urbina, EM; Xu, J	1
Abby, SL; Donovan, JM; Handelsman, Y; Jin, X; Jones, MR	1
Henney, JE	1
Zbinden, G	1

Trials

2 trial(s) available for allylamine and Adverse Drug Event

Article	Year
Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2010, Volume: 42, Issue:1 Topics: Aged; Allylamine; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Treatment Outcome	2010
Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia. The Journal of pediatrics, 2010, Volume: 156, Issue:2 Topics: Adolescent; Allylamine; Anticholesteremic Agents; Child; Cholesterol, LDL; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male	2010

Article

Year

Long-term Safety and Tolerability of Colesevelam HCl in Subjects with Type 2 Diabetes.

Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2010, Volume: 42, Issue:1

Topics: Aged; Allylamine; Colesevelam Hydrochloride; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Treatment Outcome

2010

Colesevelam hydrochloride: efficacy and safety in pediatric subjects with heterozygous familial hypercholesterolemia.

The Journal of pediatrics, 2010, Volume: 156, Issue:2

Topics: Adolescent; Allylamine; Anticholesteremic Agents; Child; Cholesterol, LDL; Colesevelam Hydrochloride; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemia Type II; Male

2010

Other Studies

3 other study(ies) available for allylamine and Adverse Drug Event

Article	Year
Colesevelam HCl improves fasting plasma glucose and lipid levels in patients with prediabetes. Postgraduate medicine, 2009, Volume: 121, Issue:6 Topics: Adult; Aged; Allylamine; Anticholesteremic Agents; Blood Glucose; Cholesterol, LDL; Colesevelam Hydrochloride; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prediabetic State; Randomized Controlled Trials as Topic	2009
From the Food and Drug Administration. JAMA, 2000, Aug-09, Volume: 284, Issue:6 Topics: Allylamine; Anticholesteremic Agents; Colesevelam Hydrochloride; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Hydrogels; Hypercholesterolemia; Lung Neoplasms; Surgical Equipment; United States; United States Food and Drug Administration	2000
Detection of cardiotoxic hazards. Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1986, Volume: 9 Topics: Allylamine; Animals; Biogenic Amines; Blood Pressure; Cardiomyopathies; Drug Evaluation, Preclinical; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Emetine; Epoxy Compounds; Female; Heart; Mice; Propionates	1986